Vident Investment Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-9,277
| Closed | -$936K | – | 701 |
|
2023
Q2 | $936K | Buy |
9,277
+1,494
| +19% | +$151K | 0.03% | 496 |
|
2023
Q1 | $716K | Buy |
7,783
+1,000
| +15% | +$92K | 0.02% | 636 |
|
2022
Q4 | $615K | Buy |
+6,783
| New | +$615K | 0.02% | 642 |
|
2022
Q3 | – | Sell |
-2,448
| Closed | -$208K | – | 1252 |
|
2022
Q2 | $208K | Buy |
+2,448
| New | +$208K | 0.01% | 1125 |
|
2018
Q4 | – | Sell |
-34,592
| Closed | -$2.67M | – | 879 |
|
2018
Q3 | $2.67M | Sell |
34,592
-2,419
| -7% | -$187K | 0.1% | 268 |
|
2018
Q2 | $2.51M | Buy |
37,011
+13,685
| +59% | +$926K | 0.1% | 278 |
|
2018
Q1 | $1.7M | Buy |
23,326
+6,830
| +41% | +$497K | 0.07% | 331 |
|
2017
Q4 | $1.24M | Buy |
16,496
+417
| +3% | +$31.4K | 0.06% | 344 |
|
2017
Q3 | $1.24M | Buy |
16,079
+486
| +3% | +$37.4K | 0.07% | 340 |
|
2017
Q2 | $1.17M | Buy |
15,593
+1,691
| +12% | +$126K | 0.1% | 307 |
|
2017
Q1 | $925K | Buy |
13,902
+2,223
| +19% | +$148K | 0.09% | 311 |
|
2016
Q4 | $762K | Buy |
11,679
+1,848
| +19% | +$121K | 0.09% | 301 |
|
2016
Q3 | $696K | Sell |
9,831
-49
| -0.5% | -$3.47K | 0.09% | 317 |
|
2016
Q2 | $730K | Sell |
9,880
-11,168
| -53% | -$825K | 0.1% | 310 |
|
2016
Q1 | $1.37K | Buy |
21,048
+10,996
| +109% | +$714 | 0.08% | 341 |
|
2015
Q4 | $775K | Buy |
+10,052
| New | +$775K | 0.1% | 337 |
|
2015
Q3 | – | Sell |
-20,300
| Closed | -$1.79M | – | 1117 |
|
2015
Q2 | $1.79M | Buy |
20,300
+4,869
| +32% | +$429K | 0.24% | 110 |
|
2015
Q1 | $1.36M | Buy |
+15,431
| New | +$1.36M | 0.27% | 79 |
|